Mandate Vinge advised Valneva SE in connection with its acquisition of Crucell Sweden AB

January 18, 2016

Vinge, in cooperation with Dechert LLP as lead legal advisor, advised Valneva SE in connection with its acquisition of Crucell Sweden AB, the Nordics vaccine distribution business of the seller (Crucell Holland B.V.) and all assets, licenses and privileges related to Dukoral®, a vaccine against cholera and, in some countries, diarrhea caused by ETEC. Valneva is a Lyon based biotechnology company listed at Euronext Paris and at the Vienna stock exchange. The consideration amounted to € 45 million and the acquisition was completed on 9 February 2015.

Vinge advised Valneva on Swedish law matters. Vinge’s team consists of M&A partner Peter Sundgren, associates Johanna Wiberg and Kajsa Hallner (M&A), Anders Morén and Josefin Larsson (banking & finance), and Amanda Knutsson and David Andersson (capital markets).

New assignment for Anders Leissner

Anders Leissner has been appointed by the Swedish government as chairman of the War Insurance Board.
February 26, 2021

Vinge is awarded “The Top Firm in Sweden” in WTR 1000’s latest ranking

Vinge receives the highest ranking in the World Trademark Review list of the year’s rankings. The firm obtains the Guide’s foremost ranking, which also highlights specific experts.
February 18, 2021

Insurance services in Sweden – a summary 2021

Vinge’s insurance team has written a brief summary of some of the main features of the Swedish regulations affecting foreign insurers with existing or contemplated business activities in Sweden.
February 09, 2021